Form 4: Vivani Medical Director Boosts Stake with $1.68M Share Purchase

Vivani Medical Director and 10% owner Gregg Williams acquired 1,575,231 shares of common stock for approximately $1.68 million through private transactions.

Summary

• Gregg Williams, a Director and 10% owner of Vivani Medical, Inc. (VANI), acquired a total of 1,575,231 shares of common stock.
• The acquisitions occurred on March 15, 2026, through two separate private sale transactions.
• The first purchase involved 1,310,680 shares at $1.03 per share, totaling $1,350,000.40, based on a Share Purchase Agreement dated May 12, 2025.
• The second purchase involved 264,551 shares at $1.26 per share, totaling $333,334.26, based on a Share Purchase Agreement dated August 11, 2025.
• Following these transactions, Gregg Williams' total beneficial ownership, directly and indirectly, amounts to 36,156,383 shares of Vivani Medical, Inc. common stock.
• The transactions were executed pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal. The significant investment by a key insider, a Director and 10% owner, demonstrates high confidence in Vivani Medical's future, which typically bodes well for shareholder sentiment.

Positives

• A Director and 10% owner, Gregg Williams, significantly increased his stake in Vivani Medical, Inc. by purchasing 1,575,231 shares.
• The total investment by Mr. Williams in these transactions amounted to approximately $1,683,334.66, demonstrating strong insider confidence.
• The purchases were made at prices of $1.03 and $1.26 per share, which were the last reported sale prices on Nasdaq prior to the respective share purchase agreement dates.
• The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-planned acquisitions and potentially a long-term investment strategy.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that significant insider buying, especially from a Director and 10% owner, often signals strong confidence in the company's future prospects, potentially indicating that the insider believes the stock is undervalued or expects positive developments. This move by Gregg Williams could be interpreted by the market as a bullish indicator for Vivani Medical, Inc., particularly given the substantial capital deployed.

Comparison to Industry Standards

• Insider buying activity, particularly by a director and significant shareholder like Gregg Williams, is generally viewed more favorably than open market purchases by retail investors, as insiders possess non-public information regarding the company's health and future.
• The scale of this purchase, totaling over $1.68 million, is substantial and exceeds typical insider purchases, suggesting a high conviction level compared to smaller, routine acquisitions often seen across the broader market.
• While specific comparable companies are not mentioned in the filing, such a large insider investment in a medical technology company like Vivani Medical, Inc. could be seen as a positive signal, especially in an industry often characterized by high R&D costs and regulatory hurdles, where management confidence is crucial.

Related Party Transactions

• The reporting person, Gregg Williams, is a Director and 10% owner of Vivani Medical, Inc.
• The transactions involved the purchase of shares in private sales, which, given the reporting person's role, are considered related party transactions in terms of disclosure and potential conflict of interest.

Stakeholder Impact

• Shareholders: Likely positive, as significant insider buying often boosts investor confidence and can signal potential future stock appreciation.
• Management: Reinforces alignment of interests between a key director and the company's performance.

Key Dates

Recommendation

The substantial insider buying by Gregg Williams, a Director and 10% owner, signals strong conviction in Vivani Medical's future prospects. Such a significant investment, totaling over $1.68 million, suggests that a key insider believes the stock is undervalued or anticipates positive developments. This action, especially when executed under a 10b5-1 plan, typically serves as a bullish indicator for seasoned investors, warranting a 'buy' recommendation.

Keywords

Vivani Medical, VANI, Gregg Williams, Insider Buying, Share Purchase, Director, 10% Owner, SEC Form 4, Stock Acquisition, Private Sale, Rule 10b5-1